Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart Failure
Alan S. Maisel, M.D., Padma Krishnaswamy, M.D., Richard M. Nowak, M.D., M.B.A., James McCord, M.D., Judd E. Hollander, M.D., Philippe Duc, M.D., Torbjørn Omland, M.D., Ph.D., Alan B. Storrow, M.D., William T. Abraham, M.D., Alan H.B. Wu, Ph.D., Paul Clopton, M.S., Philippe G. Steg, M.D., Arne Westheim, M.D., Ph.D., M.P.H., Catherine Wold Knudsen, M.D., Alberto Perez, M.D., Radmila Kazanegra, M.D., Howard C. Herrmann, M.D., Peter A. McCullough, M.D., M.P.H., for the Breathing Not Properly Multinational Study Investigators
Methods We conducted a prospective study of 1586 patients whocame to the emergency department with acute dyspnea and whoseB-type natriuretic peptide was measured with a bedside assay.The clinical diagnosis of congestive heart failure was adjudicatedby two independent cardiologists, who were blinded to the resultsof the B-type natriuretic peptide assay.
Results The final diagnosis was dyspnea due to congestive heartfailure in 744 patients (47 percent), dyspnea due to noncardiaccauses in 72 patients with a history of left ventricular dysfunction(5 percent), and no finding of congestive heart failure in 770patients (49 percent). B-type natriuretic peptide levels bythemselves were more accurate than any historical or physicalfindings or laboratory values in identifying congestive heartfailure as the cause of dyspnea. The diagnostic accuracy ofB-type natriuretic peptide at a cutoff of 100 pg per milliliterwas 83.4 percent. The negative predictive value of B-type natriureticpeptide at levels of less than 50 pg per milliliter was 96 percent.In multiple logistic-regression analysis, measurements of B-typenatriuretic peptide added significant independent predictivepower to other clinical variables in models predicting whichpatients had congestive heart failure.
Conclusions Used in conjunction with other clinical information,rapid measurement of B-type natriuretic peptide is useful inestablishing or excluding the diagnosis of congestive heartfailure in patients with acute dyspnea.
Source Information
From the University of California, San Diego, Veterans Affairs Medical Center, San Diego (A.S.M, P.K., P.C., R.K.); Henry Ford Hospital, Detroit (R.M.N., J.M.); the University of Pennsylvania, Philadelphia (J.E.H., H.C.H.); Hôpital Bichat, Paris (P.D., P.G.S.); Ullevål University Hospital, Oslo, Norway (T.O., A.W., C.W.K.); the University of Cincinnati College of Medicine, Cincinnati (A.B.S.); the University of Kentucky College of Medicine, Lexington (W.T.A.); Hartford Hospital, Hartford, Conn. (A.H.B.W., A.P.); and the University of MissouriKansas City School of Medicine, Truman Medical Center, Kansas City (P.A.M.).
Address reprint requests to Dr. Maisel at Veterans Affairs Medical Center Cardiology 111-A, 3350 La Jolla Village Dr., San Diego, CA 92161, or at amaisel{at}ucsd.edu.
B-Type Natriuretic Peptide in Heart Failure
Colli A., Fraquelli M., Conte D., Hassan Y., Shapira A. R., Hassan S., Foote R. S., Pearlman J. D., Maisel A. S., Clopton P., McCullough P. A.
Extract |
Full Text |
PDF
N Engl J Med 2002;
347:1976-1978, Dec 12, 2002.
Correspondence
This article has been cited by other articles:
Jelinek, M.
(2008). Spectrum bias: why generalists and specialists do not connect. Evid. Based Med.
13: 132-133
[Full Text]
Authors/Task Force Members, , Dickstein, K., Cohen-Solal, A., Filippatos, G., McMurray, J. J.V., Ponikowski, P., Poole-Wilson, P. A., Stromberg, A., van Veldhuisen, D. J., Atar, D., Hoes, A. W., Keren, A., Mebazaa, A., Nieminen, M., Priori, S. G., Swedberg, K., ESC Committee for Practice Guidelines (CPG), , Vahanian, A., Camm, J., De Caterina, R., Dean, V., Dickstein, K., Filippatos, G., Funck-Brentano, C., Hellemans, I., Kristensen, S. D., McGregor, K., Sechtem, U., Silber, S., Tendera, M., Widimsky, P., Zamorano, J. L., Document Reviewers, , Tendera, M., Auricchio, A., Bax, J., Bohm, M., Corra, U., della Bella, P., Elliott, P. M., Follath, F., Gheorghiade, M., Hasin, Y., Hernborg, A., Jaarsma, T., Komajda, M., Kornowski, R., Piepoli, M., Prendergast, B., Tavazzi, L., Vachiery, J.-L., Verheugt, F. W. A., Zamorano, J. L., Zannad, F.
(2008). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J
29: 2388-2442
[Full Text]
Kaski, J P, Tome-Esteban, M T, Mead-Regan, S, Pantazis, A, Marek, J, Deanfield, J E, McKenna, W J, Elliott, P M
(2008). B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy. Heart
94: 1307-1311
[Abstract][Full Text]
Ryan, A., Rosen, D. A., Tobias, J. D.
(2008). Preliminary Experience With Nesiritide in Pediatric Patients Less Than 12 Months of Age. J Intensive Care Med
23: 321-328
[Abstract]
Wang, A. Y.-M., Lai, K.-N.
(2008). Use of Cardiac Biomarkers in End-Stage Renal Disease. J. Am. Soc. Nephrol.
19: 1643-1652
[Abstract][Full Text]
Klok, F. A., Mos, I. C. M., Huisman, M. V.
(2008). Brain-Type Natriuretic Peptide Levels in the Prediction of Adverse Outcome in Patients with Pulmonary Embolism: A Systematic Review and Meta-analysis. Am. J. Respir. Crit. Care Med.
178: 425-430
[Abstract][Full Text]
Maisel, A. S., Peacock, W. F., McMullin, N., Jessie, R., Fonarow, G. C., Wynne, J., Mills, R. M.
(2008). Timing of Immunoreactive B-Type Natriuretic Peptide Levels and Treatment Delay in Acute Decompensated Heart Failure: An ADHERE (Acute Decompensated Heart Failure National Registry) Analysis. J Am Coll Cardiol
52: 534-540
[Abstract][Full Text]
Daniels, L. B., Laughlin, G. A., Clopton, P., Maisel, A. S., Barrett-Connor, E.
(2008). Minimally Elevated Cardiac Troponin T and Elevated N-Terminal Pro-B-Type Natriuretic Peptide Predict Mortality in Older Adults: Results From the Rancho Bernardo Study. J Am Coll Cardiol
52: 450-459
[Abstract][Full Text]
Warwick, G., Thomas, P. S., Yates, D. H.
(2008). Biomarkers in pulmonary hypertension. Eur Respir J
32: 503-512
[Abstract][Full Text]
Fenske, W., Stork, S., Koschker, A.-C., Blechschmidt, A., Lorenz, D., Wortmann, S., Allolio, B.
(2008). Value of Fractional Uric Acid Excretion in Differential Diagnosis of Hyponatremic Patients on Diuretics. J. Clin. Endocrinol. Metab.
93: 2991-2997
[Abstract][Full Text]
Ray, P., Delerme, S., Jourdain, P., Chenevier-Gobeaux, C.
(2008). Differential diagnosis of acute dyspnea: the value of B natriuretic peptides in the emergency department. QJM
0: hcn080v1-hcn080
[Abstract][Full Text]
Neuhold, S., Huelsmann, M., Strunk, G., Stoiser, B., Struck, J., Morgenthaler, N. G., Bergmann, A., Moertl, D., Berger, R., Pacher, R.
(2008). Comparison of Copeptin, B-Type Natriuretic Peptide, and Amino-Terminal Pro-B-Type Natriuretic Peptide in Patients With Chronic Heart Failure: Prediction of Death at Different Stages of the Disease. J Am Coll Cardiol
52: 266-272
[Abstract][Full Text]
Michielsen, E. C H J, Bakker, J. A, Kimmenade, R. R J V., Pinto, Y. M, Dieijen-Visser, M. P V.
(2008). The diagnostic value of serum and urinary NT-proBNP for heart failure. Ann Clin Biochem
45: 389-394
[Abstract][Full Text]
La Gerche, A, Connelly, K A, Mooney, D J, MacIsaac, A I, Prior, D L
(2008). Biochemical and functional abnormalities of left and right ventricular function after ultra-endurance exercise. Heart
94: 860-866
[Abstract][Full Text]
Chung, T, Lim, W-C, Sy, R, Cunningham, I, Trotman, J, Kritharides, L
(2008). Subacute cardiac toxicity following autologous haematopoietic stem cell transplantation in patients with normal cardiac function. Heart
94: 911-918
[Abstract][Full Text]
Farombi-Oghuvbu, I, Matthews, T, Mayne, P D, Guerin, H, Corcoran, J D
(2008). N-terminal pro-B-type natriuretic peptide: a measure of significant patent ductus arteriosus. Arch. Dis. Child. Fetal Neonatal Ed.
93: F257-F260
[Abstract][Full Text]
Nishii, M., Inomata, T., Takehana, H., Naruke, T., Yanagisawa, T., Moriguchi, M., Takeda, S., Izumi, T.
(2008). Prognostic utility of B-type natriuretic peptide assessment in stable low-risk outpatients with nonischemic cardiomyopathy after decompensated heart failure.. J Am Coll Cardiol
51: 2329-2335
[Abstract][Full Text]
Mills, R. M.
(2008). Learning to use a biomarker. More about B-type natriuretic peptide.. J Am Coll Cardiol
51: 2336-2338
[Full Text]
Maher, K. O., Reed, H., Cuadrado, A., Simsic, J., Mahle, W. T., DeGuzman, M., Leong, T., Bandyopadhyay, S.
(2008). B-Type Natriuretic Peptide in the Emergency Diagnosis of Critical Heart Disease in Children. Pediatrics
121: e1484-e1488
[Abstract][Full Text]
Braunwald, E.
(2008). Biomarkers in Heart Failure. NEJM
358: 2148-2159
[Full Text]
Waldo, S. W., Beede, J., Isakson, S., Villard-Saussine, S., Fareh, J., Clopton, P., Fitzgerald, R. L., Maisel, A. S.
(2008). Pro-B-Type Natriuretic Peptide Levels in Acute Decompensated Heart Failure. J Am Coll Cardiol
51: 1874-1882
[Abstract][Full Text]
Hillock, R J, Frampton, C M, Yandle, T G, Troughton, R W, Lainchbury, J G, Richards, A M
(2008). B-type natriuretic peptide infusions in acute myocardial infarction. Heart
94: 617-622
[Abstract][Full Text]
Parissis, J T, Nikolaou, M, Farmakis, D, Bistola, V, Paraskevaidis, I A, Adamopoulos, S, Filippatos, G, Kremastinos, D T
(2008). Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure. Heart
94: 585-589
[Abstract][Full Text]
Green, S. M., Martinez-Rumayor, A., Gregory, S. A., Baggish, A. L., O'Donoghue, M. L., Green, J. A., Lewandrowski, K. B., Januzzi, J. L. Jr
(2008). Clinical Uncertainty, Diagnostic Accuracy, and Outcomes in Emergency Department Patients Presenting With Dyspnea. Arch Intern Med
168: 741-748
[Abstract][Full Text]
Pascual-Figal, D. A., Domingo, M., Casas, T., Gich, I., Ordonez-Llanos, J., Martinez, P., Cinca, J., Valdes, M., Januzzi, J. L., Bayes-Genis, A.
(2008). Usefulness of clinical and NT-proBNP monitoring for prognostic guidance in destabilized heart failure outpatients. Eur Heart J
29: 1011-1018
[Abstract][Full Text]
Pang, P. S., Cleland, J. G.F., Teerlink, J. R., Collins, S. P., Lindsell, C. J., Sopko, G., Peacock, W. F., Fonarow, G. C., Aldeen, A. Z., Kirk, J. D., Storrow, A. B., Tavares, M., Mebazaa, A., Roland, E., Massie, B. M., Maisel, A. S., Komajda, M., Filippatos, G., Gheorghiade, M., for the Acute Heart Failure Syndromes Internationa,
(2008). A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach. Eur Heart J
29: 816-824
[Abstract][Full Text]
Zannad, F., Stough, W. G., Pitt, B., Cleland, J. G.F., Adams, K. F., Geller, N. L., Torp-Pedersen, C., Kirwan, B.-A., Follath, F.
(2008). Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition. Eur Heart J
29: 413-421
[Abstract][Full Text]
Walsh, R., Boyer, C., LaCorte, J., Parnell, V., Sison, C., Chowdhury, D., Ojamaa, K.
(2008). N-terminal B-type natriuretic peptide levels in pediatric patients with congestive heart failure undergoing cardiac surgery. J. Thorac. Cardiovasc. Surg.
135: 98-105
[Abstract][Full Text]
Moe, G. W., Howlett, J., Januzzi, J. L., Zowall, H.
(2008). Response to Letter Regarding Article, "N-Terminal Pro B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study". Circulation
117: e6-e6
[Full Text]
Daniels, L. B., Maisel, A. S.
(2007). Natriuretic Peptides. J Am Coll Cardiol
50: 2357-2368
[Abstract][Full Text]
Mainwaring, R. D., Parise, C., Wright, S. B., Juris, A. L., Achtel, R. A., Fallah, H.
(2007). Brain Natriuretic Peptide Levels Before and After Ventricular Septal Defect Repair. Ann. Thorac. Surg.
84: 2066-2069
[Abstract][Full Text]
Rivers, E. P., McCord, J., Otero, R., Jacobsen, G., Loomba, M.
(2007). Clinical utility of B-type natriuretic peptide in early severe sepsis and septic shock.. J Intensive Care Med
22: 363-373
[Abstract]
Mogelvang, R., Goetze, J. P., Schnohr, P., Lange, P., Sogaard, P., Rehfeld, J. F., Jensen, J. S.
(2007). Discriminating Between Cardiac and Pulmonary Dysfunction in the General Population With Dyspnea by Plasma Pro-B-Type Natriuretic Peptide. J Am Coll Cardiol
50: 1694-1701
[Abstract][Full Text]
Mueller, C.
(2007). B-Type Natriuretic Peptides and the General Practitioner. J Am Coll Cardiol
50: 1702-1703
[Full Text]
Maisel, A.
(2007). Biomarkers in Heart Failure: Does Prognostic Utility Translate to Clinical Futility?. J Am Coll Cardiol
50: 1061-1063
[Full Text]
Quintas-Cardama, A., Kantarjian, H., O'Brien, S., Borthakur, G., Bruzzi, J., Munden, R., Cortes, J.
(2007). Pleural Effusion in Patients With Chronic Myelogenous Leukemia Treated With Dasatinib After Imatinib Failure. JCO
25: 3908-3914
[Abstract][Full Text]
Pascual-Figal, D. A, Antolinos, M. J, Bayes-Genis, A., Casas, T., Nicolas, F., Valdes, M.
(2007). B-type natriuretic peptide release in the coronary effluent after acute transient ischaemia in humans. Heart
93: 1077-1080
[Abstract][Full Text]
Januzzi, J. L. Jr, Peacock, W. F., Maisel, A. S., Chae, C. U., Jesse, R. L., Baggish, A. L., O'Donoghue, M., Sakhuja, R., Chen, A. A., van Kimmenade, R. R.J., Lewandrowski, K. B., Lloyd-Jones, D. M., Wu, A. H.B.
(2007). Measurement of the Interleukin Family Member ST2 in Patients With Acute Dyspnea: Results From the PRIDE (Pro-Brain Natriuretic Peptide Investigation of Dyspnea in the Emergency Department) Study. J Am Coll Cardiol
50: 607-613
[Abstract][Full Text]
Cuthbertson, B. H., Amiri, A. R., Croal, B. L., Rajagopalan, S., Alozairi, O., Brittenden, J., Hillis, G. S.
(2007). Utility of B-type natriuretic peptide in predicting perioperative cardiac events in patients undergoing major non-cardiac surgery. Br J Anaesth
99: 170-176
[Abstract][Full Text]
Breidthardt, T., Laule, K., Strohmeyer, A.-H., Schindler, C., Meier, S., Fischer, M., Scholer, A., Noveanu, M., Christ, M., Perruchoud, A. P., Mueller, C.
(2007). Medical and Economic Long-term Effects of B-Type Natriuretic Peptide Testing in Patients with Acute Dyspnea. Clin. Chem.
53: 1415-1422
[Abstract][Full Text]
deFilippi, C. R., Seliger, S. L., Maynard, S., Christenson, R. H.
(2007). Impact of Renal Disease on Natriuretic Peptide Testing for Diagnosing Decompensated Heart Failure and Predicting Mortality. Clin. Chem.
53: 1511-1519
[Abstract][Full Text]
Apple, F. S., Wu, A. H.B., Jaffe, A. S., Panteghini, M., Christenson, R. H., NACB COMMITTEE MEMBERS, , Christenson, R. H., Apple, F. S., Cannon, C. P., Francis, G., Jesse, R. L., Morrow, D. A., Newby, L. K., Storrow, A. B., Tang, W.H. W., Wu, A. H.B., IFCC COMMITTEE ON STANDARDIZATION OF MARKERS OF CA, , Apple, F. S., Christenson, R. H., Jaffe, A. S., Pagani, F., Tate, J., Ordonez-Llanos, J., Mair, J.
(2007). National Academy of Clinical Biochemistry and IFCC Committee for Standardization of Markers of Cardiac Damage Laboratory Medicine Practice Guidelines: Analytical Issues for Biomarkers of Heart Failure. Circulation
116: e95-e98
[Full Text]
Wilson Tang, W.H., Francis, G. S., Morrow, D. A., Newby, L. K., Cannon, C. P., Jesse, R. L., Storrow, A. B., Christenson, R. H., COMMITTEE MEMBERS, , Christenson, R. H., Apple, F. S., Cannon, C. P., Francis, G. S., Jesse, R. L., Morrow, D. A., Newby, L. K., Ravkilde, J., Storrow, A. B., Tang, W.H. W., Wu, A. H.B.
(2007). National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: Clinical Utilization of Cardiac Biomarker Testing in Heart Failure. Circulation
116: e99-e109
[Full Text]
Omland, T., Sabatine, M. S., Jablonski, K. A., Rice, M. M., Hsia, J., Wergeland, R., Landaas, S., Rouleau, J. L., Domanski, M. J., Hall, C., Pfeffer, M. A., Braunwald, E., for the PEACE Investigators,
(2007). Prognostic Value of B-Type Natriuretic Peptides in Patients With Stable Coronary Artery Disease: The PEACE Trial. J Am Coll Cardiol
50: 205-214
[Abstract][Full Text]
Spanaus, K.-S., Kronenberg, F., Ritz, E., Schlapbach, R., Fliser, D., Hersberger, M., Kollerits, B., Konig, P., von Eckardstein, A., for the Mild-to-Moderate Kidney Disease Study Grou,
(2007). B-Type Natriuretic Peptide Concentrations Predict the Progression of Nondiabetic Chronic Kidney Disease: The Mild-to-Moderate Kidney Disease Study. Clin. Chem.
53: 1264-1272
[Abstract][Full Text]
Emdin, M., Passino, C., Prontera, C., Fontana, M., Poletti, R., Gabutti, A., Mammini, C., Giannoni, A., Zyw, L., Zucchelli, G., Clerico, A.
(2007). Comparison of Brain Natriuretic Peptide (BNP) and Amino-Terminal ProBNP for Early Diagnosis of Heart Failure. Clin. Chem.
53: 1289-1297
[Abstract][Full Text]
Greenberg, B.
(2007). Can We IMPROVE-CHF Management By Measuring Natriuretic Peptides?. Circulation
115: 3045-3047
[Full Text]
Moe, G. W., Howlett, J., Januzzi, J. L., Zowall, H., for the Canadian Multicenter Improved Management o,
(2007). N-Terminal Pro-B-Type Natriuretic Peptide Testing Improves the Management of Patients With Suspected Acute Heart Failure: Primary Results of the Canadian Prospective Randomized Multicenter IMPROVE-CHF Study. Circulation
115: 3103-3110
[Abstract][Full Text]
Bergler-Klein, J., Mundigler, G., Pibarot, P., Burwash, I. G., Dumesnil, J. G., Blais, C., Fuchs, C., Mohty, D., Beanlands, R. S., Hachicha, Z., Walter-Publig, N., Rader, F., Baumgartner, H.
(2007). B-Type Natriuretic Peptide in Low-Flow, Low-Gradient Aortic Stenosis: Relationship to Hemodynamics and Clinical Outcome: Results From the Multicenter Truly or Pseudo-Severe Aortic Stenosis (TOPAS) Study. Circulation
115: 2848-2855
[Abstract][Full Text]
Carrillo-Jimenez, R., Borzak, S., Hennekens, C. H.
(2007). Brain Natriuretic Peptide: Clinical and Research Challenges. J CARDIOVASC PHARMACOL THER
12: 85-88
[Abstract]
Ahmed, W., Zafar, S., Alam, A. Y., Ahktar, N., Shah, M. A., Alpert, M. A.
(2007). Plasma Levels of B-Type Natriuretic Peptide in Patients With Unstable Angina Pectoris or Acute Myocardial Infarction: Prognostic Significance and Therapeutic Implications. ANGIOLOGY
58: 269-274
[Abstract]
Pirracchio, R., Cholley, B., De Hert, S., Solal, A. C., Mebazaa, A.
(2007). Diastolic heart failure in anaesthesia and critical care. Br J Anaesth
98: 707-721
[Abstract][Full Text]
Noda, A., Izawa, H., Asano, H., Nakata, S., Hirashiki, A., Murase, Y., Iino, S., Nagata, K., Murohara, T., Koike, Y., Yokota, M.
(2007). Beneficial Effect of Bilevel Positive Airway Pressure on Left Ventricular Function in Ambulatory Patients With Idiopathic Dilated Cardiomyopathy and Central Sleep Apnea-Hypopnea: A Preliminary Study. Chest
131: 1694-1701
[Abstract][Full Text]
Fonarow, G. C., Peacock, W. F., Phillips, C. O., Givertz, M. M., Lopatin, M., for the ADHERE Scientific Advisory Committee and I,
(2007). Admission B-Type Natriuretic Peptide Levels and In-Hospital Mortality in Acute Decompensated Heart Failure. J Am Coll Cardiol
49: 1943-1950
[Abstract][Full Text]
Choi, S., Park, D., Lee, S., Hong, Y., Kim, S., Lee, J.
(2007). Cut-off values of B-type natriuretic peptide for the diagnosis of congestive heart failure in patients with dyspnoea visiting emergency departments: a study on Korean patients visiting emergency departments. Emerg. Med. J.
24: 343-347
[Abstract][Full Text]
Cannesson, M., Bionda, C., Gostoli, B., Raisky, O., di Filippo, S., Bompard, D., Vedrinne, C., Rousson, R., Ninet, J., Neidecker, J., Lehot, J.-J.
(2007). Time Course and Prognostic Value of Plasma B-type Natriuretic Peptide Concentration in Neonates Undergoing the Arterial Switch Operation. Anesth. Analg.
104: 1059-1065
[Abstract][Full Text]
Heublein, D. M., Huntley, B. K., Boerrigter, G., Cataliotti, A., Sandberg, S. M., Redfield, M. M., Burnett, J. C. Jr
(2007). Immunoreactivity and Guanosine 3',5'-Cyclic Monophosphate Activating Actions of Various Molecular Forms of Human B-Type Natriuretic Peptide. Hypertension
49: 1114-1119
[Abstract][Full Text]
Jourdain, P., Jondeau, G., Funck, F., Gueffet, P., Le Helloco, A., Donal, E., Aupetit, J. F., Aumont, M. C., Galinier, M., Eicher, J. C., Cohen-Solal, A., Juilliere, Y.
(2007). Plasma Brain Natriuretic Peptide-Guided Therapy to Improve Outcome in Heart Failure: The STARS-BNP Multicenter Study. J Am Coll Cardiol
49: 1733-1739
[Abstract][Full Text]
Karmpaliotis, D., Kirtane, A. J., Ruisi, C. P., Polonsky, T., Malhotra, A., Talmor, D., Kosmidou, I., Jarolim, P., de Lemos, J. A., Sabatine, M. S., Gibson, C. M., Morrow, D.
(2007). Diagnostic and Prognostic Utility of Brain Natriuretic Peptide in Subjects Admitted to the ICU With Hypoxic Respiratory Failure Due to Noncardiogenic and Cardiogenic Pulmonary Edema. Chest
131: 964-971
[Abstract][Full Text]
Allen, L. A., O'Connor, C. M.
(2007). Management of acute decompensated heart failure. CMAJ
176: 797-805
[Abstract][Full Text]
Liang, F., O'Rear, J., Schellenberger, U., Tai, L., Lasecki, M., Schreiner, G. F., Apple, F. S., Maisel, A. S., Pollitt, N. S., Protter, A. A.
(2007). Evidence for Functional Heterogeneity of Circulating B-Type Natriuretic Peptide. J Am Coll Cardiol
49: 1071-1078
[Abstract][Full Text]
Naegeli, B., Kurz, D. J., Koller, D., Straumann, E., Furrer, M., Maurer, D., Minder, E., Bertel, O.
(2007). Single-chamber ventricular pacing increases markers of left ventricular dysfunction compared with dual-chamber pacing. Europace
9: 194-199
[Abstract][Full Text]
McLachlan, C. S., Yu, H., Mossop, P.
(2007). Natriuretic peptides and heart failure. CMAJ
176: 659-659
[Full Text]
Heart Protection Study Collaborative Group,*,
(2007). N-Terminal Pro-B-Type Natriuretic Peptide, Vascular Disease Risk, and Cholesterol Reduction Among 20,536 Patients in the MRC/BHF Heart Protection Study. J Am Coll Cardiol
49: 311-319
[Abstract][Full Text]
Konstam, M. A.
(2007). Natriuretic Peptides and Cardiovascular Events: More Than a Stretch. JAMA
297: 212-214
[Full Text]
Redwine, L. S., Mills, P. J., Hong, S., Rutledge, T., Reis, V., Maisel, A., Irwin, M. R.
(2007). Cardiac-related Hospitalization and/or Death Associated With Immune Dysregulation and Symptoms of Depression in Heart Failure Patients. Psychosom. Med.
69: 23-29
[Abstract][Full Text]
Wang, A. Y.-M., Lam, C. W.-K., Yu, C.-M., Wang, M., Chan, I. H.-S., Zhang, Y., Lui, S.-F., Sanderson, J. E.
(2007). N-Terminal Pro-Brain Natriuretic Peptide: An Independent Risk Predictor of Cardiovascular Congestion, Mortality, and Adverse Cardiovascular Outcomes in Chronic Peritoneal Dialysis Patients. J. Am. Soc. Nephrol.
18: 321-330
[Abstract][Full Text]
Maceira, A. M., Prasad, S. K., Khan, M., Pennell, D. J.
(2006). Reference right ventricular systolic and diastolic function normalized to age, gender and body surface area from steady-state free precession cardiovascular magnetic resonance. Eur Heart J
27: 2879-2888
[Abstract][Full Text]
Coste, J., Jourdain, P., Pouchot, J.
(2006). A Gray Zone Assigned to Inconclusive Results of Quantitative Diagnostic Tests: Application to the Use of Brain Natriuretic Peptide for Diagnosis of Heart Failure in Acute Dyspneic Patients. Clin. Chem.
52: 2229-2235
[Abstract][Full Text]
Bursi, F., Weston, S. A., Redfield, M. M., Jacobsen, S. J., Pakhomov, S., Nkomo, V. T., Meverden, R. A., Roger, V. L.
(2006). Systolic and diastolic heart failure in the community.. JAMA
296: 2209-2216
[Abstract][Full Text]
Christ, M., Laule-Kilian, K., Hochholzer, W., Klima, T., Breidthardt, T., Perruchoud, A. P., Mueller, C.
(2006). Gender-Specific Risk Stratification With B-Type Natriuretic Peptide Levels in Patients With Acute Dyspnea: Insights From the B-type Natriuretic Peptide for Acute Shortness of Breath Evaluation Study. J Am Coll Cardiol
48: 1808-1812
[Abstract][Full Text]
Ammar, H., Malani, A. K., Gupta, C., Dobyan, D. C.
(2006). Brain Natriuretic Peptide, Clinical Reasoning, and Congestive Heart Failure. Am J Crit Care
15: 614-616
[Full Text]
Abroug, F., Ouanes-Besbes, L., Nciri, N., Sellami, N., Addad, F., Hamda, K. B., Amor, A. B., Najjar, M. F., Knani, J.
(2006). Association of Left-Heart Dysfunction with Severe Exacerbation of Chronic Obstructive Pulmonary Disease: Diagnostic Performance of Cardiac Biomarkers. Am. J. Respir. Crit. Care Med.
174: 990-996
[Abstract][Full Text]
van Kimmenade, R. R.J., Januzzi, J. L. Jr, Baggish, A. L., Lainchbury, J. G., Bayes-Genis, A., Richards, A. M., Pinto, Y. M.
(2006). Amino-Terminal Pro-Brain Natriuretic Peptide, Renal Function, and Outcomes in Acute Heart Failure: Redefining the Cardiorenal Interaction?. J Am Coll Cardiol
48: 1621-1627
[Abstract][Full Text]
van Kimmenade, R. R., Januzzi, J. L. Jr, Ellinor, P. T., Sharma, U. C., Bakker, J. A., Low, A. F., Martinez, A., Crijns, H. J., MacRae, C. A., Menheere, P. P., Pinto, Y. M.
(2006). Utility of Amino-Terminal Pro-Brain Natriuretic Peptide, Galectin-3, and Apelin for the Evaluation of Patients With Acute Heart Failure. J Am Coll Cardiol
48: 1217-1224
[Abstract][Full Text]
Felker, G. M., Petersen, J. W., Mark, D. B.
(2006). Natriuretic peptides in the diagnosis and management of heart failure.. CMAJ
175: 611-617
[Abstract][Full Text]
Januzzi, J. L., Lloyd-Jones, D. M., Anwaruddin, S.
(2006). Reply. J Am Coll Cardiol
48: 1061-1061
[Full Text]
Price, J. F., Thomas, A. K., Grenier, M., Eidem, B. W., Smith, E. O., Denfield, S. W., Towbin, J. A., Dreyer, W. J.
(2006). B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Events in Pediatric Outpatients With Chronic Left Ventricular Systolic Dysfunction. Circulation
114: 1063-1069
[Abstract][Full Text]
Aspromonte, N., Ceci, V., Chiera, A., Coletta, C., D'Eri, A., Feola, M., Giovinazzo, P., Milani, L., Noventa, F., Scardovi, A. B., Sestili, A., Valle, R.
(2006). Rapid Brain Natriuretic Peptide Test and Doppler Echocardiography for Early Diagnosis of Mild Heart Failure. Clin. Chem.
52: 1802-1808
[Abstract][Full Text]
Blankenberg, S., McQueen, M. J., Smieja, M., Pogue, J., Balion, C., Lonn, E., Rupprecht, H. J., Bickel, C., Tiret, L., Cambien, F., Gerstein, H., Munzel, T., Yusuf, S., for the HOPE Study Investigators,
(2006). Comparative Impact of Multiple Biomarkers and N-Terminal Pro-Brain Natriuretic Peptide in the Context of Conventional Risk Factors for the Prediction of Recurrent Cardiovascular Events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation
114: 201-208
[Abstract][Full Text]